Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What influences placebo and nocebo responses in Parkinson's disease?

Movement disorders : official journal of the Movement Disorder Society - 1 Aug 2018

Witek Natalie, Stebbins Glenn T, Goetz Christopher G

Abstract excerpt

Placebo treatment is associated with clinical improvements in many medical conditions, but is particularly important in Parkinson's disease because improvements are common, marked, and associated with objective neurochemical and neurophysiologic changes. This review will focus on the effect of the placebo in patients with PD and will discuss the pathophysiology, observed characteristics of motor and nonmotor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Catechol O-Methyltransferase
Share to History, 18th Century

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to History, 19th Century

Share to Parkinson Disease

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Identifiers

PMID: 30132980
DOI: 10.1002/mds.27416

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What influences placebo and nocebo responses in Parkinson's disease?PMID 30132980Read ↗

Low dose niacin versus placebo in the treatment of Parkinson’s Disease: A Randomized Controlled TrialSemantic proximity Read ↗

Genetics and the placebo effect: the placebome.Semantic proximity Read ↗

Mechanisms of the placebo effect in pain and psychiatric disorders.Semantic proximity Read ↗

Exploring Fatigue in Parkinson’s Disease: A Comprehensive Literature ReviewSemantic proximity Read ↗

Parkinson’s disease: Individual placebo responses are predicted by baseline expression of a striato-limbic networkSemantic proximity Read ↗

Physical therapy in patients with Parkinson’s disease treated with Deep Brain Stimulation: a Delphi panel studySemantic proximity Read ↗

A High Dose Tango Intervention for People with Parkinson’s disease (PwPD)Semantic proximity Read ↗

Next-Generation Cranial Nerve Stimulation and Neuromodulation Techniques: Potential and Clinical Applications in Parkinson’s Disease TreatmentSemantic proximity Read ↗

GABAergic dysfunction in Parkinson’s disease: Insights from in vivo proton magnetic resonance spectroscopySemantic proximity Read ↗

Non-Categorical Analyses Identify Rotenone-Induced 'Parkinsonian' Rats Benefiting from Nano-Emulsified Punicic Acid (Nano-PSO) in a Phenotypically Diverse Population: Implications for Translational Neurodegenerative Therapies.Semantic proximity Read ↗

Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease.Semantic proximity Read ↗

Propranolol reduces Parkinson’s tremor and inhibits tremor-related activity in the motor cortex: a placebo-controlled crossover trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.